341 related articles for article (PubMed ID: 36765583)
1. Machine Learning to Predict the Response to Lenvatinib Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma.
Ma J; Bo Z; Zhao Z; Yang J; Yang Y; Li H; Yang Y; Wang J; Su Q; Wang J; Chen K; Yu Z; Wang Y; Chen G
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765583
[TBL] [Abstract][Full Text] [Related]
2. Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning.
Liu W; Wei R; Chen J; Li Y; Pang H; Zhang W; An C; Li C
Eur Radiol; 2024 Jan; ():. PubMed ID: 38291256
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Early Treatment Response to Initial Conventional Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma by Machine-Learning Model Based on Computed Tomography.
Dong Z; Lin Y; Lin F; Luo X; Lin Z; Zhang Y; Li L; Li ZP; Feng ST; Cai H; Peng Z
J Hepatocell Carcinoma; 2021; 8():1473-1484. PubMed ID: 34877267
[TBL] [Abstract][Full Text] [Related]
4. Predictive model and risk analysis for peripheral vascular disease in type 2 diabetes mellitus patients using machine learning and shapley additive explanation.
Liu L; Bi B; Cao L; Gui M; Ju F
Front Endocrinol (Lausanne); 2024; 15():1320335. PubMed ID: 38481447
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study.
Chen R; Li L; Li Y; Song K; Shen C; Ma P; Wang Z
J Gastrointest Oncol; 2022 Jun; 13(3):1367-1375. PubMed ID: 35837188
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and predictive factors of transarterial chemoembolization combined with lenvatinib plus programmed cell death protein-1 inhibition for unresectable hepatocellular carcinoma.
Ma KP; Fu JX; Duan F; Wang MQ
World J Gastrointest Oncol; 2024 Apr; 16(4):1236-1247. PubMed ID: 38660650
[TBL] [Abstract][Full Text] [Related]
7. Application of machine learning model in predicting the likelihood of blood transfusion after hip fracture surgery.
Chen X; Pan J; Li Y; Tang R
Aging Clin Exp Res; 2023 Nov; 35(11):2643-2656. PubMed ID: 37733228
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the development of acute kidney injury following cardiac surgery by machine learning.
Tseng PY; Chen YT; Wang CH; Chiu KM; Peng YS; Hsu SP; Chen KL; Yang CY; Lee OK
Crit Care; 2020 Jul; 24(1):478. PubMed ID: 32736589
[TBL] [Abstract][Full Text] [Related]
9. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib, Lenvatinib, or Lenvatinib Combining PD-1 Inhibitors Plus TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Analysis.
Zhao S; Zhou M; Wang P; Yang J; Zhang D; Yin F; Song P
Technol Cancer Res Treat; 2022; 21():15330338221133640. PubMed ID: 36259214
[No Abstract] [Full Text] [Related]
11. Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study.
Fu Z; Li X; Zhong J; Chen X; Cao K; Ding N; Liu L; Zhang X; Zhai J; Qu Z
Hepatol Int; 2021 Jun; 15(3):663-675. PubMed ID: 33877527
[TBL] [Abstract][Full Text] [Related]
12. A Risk Prediction Model for Physical Restraints Among Older Chinese Adults in Long-term Care Facilities: Machine Learning Study.
Wang J; Chen H; Wang H; Liu W; Peng D; Zhao Q; Xiao M
J Med Internet Res; 2023 Apr; 25():e43815. PubMed ID: 37023416
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A comparative retrospective study.
Zhang JX; Chen YX; Zhou CG; Liu J; Liu S; Shi HB; Zu QQ
Hepatol Res; 2022 Sep; 52(9):794-803. PubMed ID: 35698267
[TBL] [Abstract][Full Text] [Related]
14. An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma.
Zhang L; Jin Z; Li C; He Z; Zhang B; Chen Q; You J; Ma X; Shen H; Wang F; Wu L; Ma C; Zhang S
Radiol Med; 2024 Mar; 129(3):353-367. PubMed ID: 38353864
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
Ding X; Sun W; Li W; Shen Y; Guo X; Teng Y; Liu X; Zheng L; Li W; Chen J
Cancer; 2021 Oct; 127(20):3782-3793. PubMed ID: 34237154
[TBL] [Abstract][Full Text] [Related]
16. Impact of combining Lenvatinib with Transarterial chemoembolization for unresectable hepatocellular carcinoma.
Long J; Liu L; Yang X; Lu X; Qin L
Pak J Med Sci; 2023; 39(6):1847-1852. PubMed ID: 37936761
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study.
Cao F; Yang Y; Si T; Luo J; Zeng H; Zhang Z; Feng D; Chen Y; Zheng J
Front Oncol; 2021; 11():783480. PubMed ID: 34988019
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Efficacy and Safety of Transarterial Chemoembolization with or without Lenvatinib for Unresectable Hepatocellular Carcinoma: A Retrospective Propensity Score-Matched Analysis.
Chen YX; Zhang JX; Zhou CG; Liu J; Liu S; Shi HB; Zu QQ
J Hepatocell Carcinoma; 2022; 9():685-694. PubMed ID: 35937909
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report.
Mu C; Shen J; Zhu X; Peng W; Zhang X; Wen T
Front Oncol; 2023; 13():1096955. PubMed ID: 37260972
[TBL] [Abstract][Full Text] [Related]
20. Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study.
Wang ZX; Wang EX; Bai W; Xia DD; Mu W; Li J; Yang QY; Huang M; Xu GH; Sun JH; Li HL; Zhao H; Wu JB; Yang SF; Li JP; Li ZX; Zhang CQ; Zhu XL; Zheng YB; Wang QH; Li J; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH; On Behalf Of China Hcc-Tace Study Group
World J Gastroenterol; 2020 Feb; 26(6):657-669. PubMed ID: 32103874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
